Choriocarcinoma in neonates and infants: A severe but curable disease.
Marie Pierre CastexJoanna StefanowiczLaura ClementJadwiga Węcławek-TompolFrederic HameuryBrice FresneauSabine IrtanAnne Cecile BrunacDanuta Januszkiewicz-LewandowskaBrigitte LacourCécile Faure-ConterDaniel OrbachPublished in: Pediatric blood & cancer (2024)
Choriocarcinoma in neonates and infants (N-CC) is an extremely rare, but aggressive cancer, frequently observed with concomitant maternal disease. A retrospective, bi-national study of patients treated in France and Poland for infantile choriocarcinoma analysed eight cases of N-CC, median age of 6 weeks. All tumours were diffuse. Six patients received a platinum-based regimen, and five had delayed surgery on residual distant tumour sites. At the end of follow-up, four patients were in complete remission and four had died of the disease. In all but two cases, mothers had simultaneous metastatic choriocarcinoma. Even if the outcome remains poor, patients could be cured with multimodal therapy.
Keyphrases
- ejection fraction
- newly diagnosed
- prognostic factors
- squamous cell carcinoma
- stem cells
- lymph node
- rheumatoid arthritis
- mesenchymal stem cells
- pregnant women
- low birth weight
- chronic pain
- early onset
- young adults
- patient reported outcomes
- quality improvement
- percutaneous coronary intervention
- preterm birth
- squamous cell
- ulcerative colitis